期刊文献+

骨桥蛋白及其信号通路对肿瘤侵袭调控的研究进展 被引量:11

Progress in research of osteopontin and its signal transduction pathway in tumor metastasis
下载PDF
导出
摘要 骨桥蛋白(osteopontin,OPN)是一种分泌型磷酸化糖蛋白,其分子结构中含有精氨酸-甘氨酸-天冬氨酸(RGD)的受体结合序列。OPN主要通过与其受体整合素和CD44相互作用,参与肿瘤转移的多个过程。近年来,骨桥蛋白及其调控肿瘤侵袭与转移的信号通路倍受关注。OPN通过与整合素ανβ3和CD44结合作用,使多种激酶(PI3K、NIK、PLC、PKC和MAPK)磷酸化激活,从而发挥抑制凋亡和激活多种基质降解蛋白酶(uPA和MMPs)的功能,促进肿瘤细胞转移。 Osteopontin (OPN) is a secreted glyco-phosphoprotein that contains a conserved Gly-Arg-Gly-Asp-Ser (GRGDS) sequence, Osteopontin mainly participates in a number Of process of tumor metastasis through binding with integrin and CD44 receptors, Recently, osteopontin and its signaling pathway in the regulation of tumor invasion and metastasis have aroused concern, Osteopontin can activate the phosphorylation of several kinases (P13K, NIK, PLC, PKC, MAPK) by interacting with integrin avβ3 and CD44 receptors,thereby plays a crucial role in inhibiting apoptosis and activation of matrix degradation of a variety of proteases (uPA and MMPs) which ultimately promotes tumor metastasis,
出处 《中华肿瘤防治杂志》 CAS 2008年第5期393-395,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金资助(30472261)
关键词 信号传递 肿瘤转移 抗原 CD44 综述文献 signal transduction neoplasms metastasis, antigens, CD44 review literature
  • 相关文献

参考文献16

  • 1Wai P Y, Kuo P C. The role of osteopontin in tumor metastasis[J]. J Surg Res, 2004, 121(2): 228-241. 被引量:1
  • 2Tuck A B, Hota C, Wilson S M, et al. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways[J]. Oncogene, 2003,22(8) : 1198-1205. 被引量:1
  • 3Pan H W, Ou Y H , Peng S Y, et al. Over expression of osteopontin isassociated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma[J] . Cancer,2003, 98(1): 119-127. 被引量:1
  • 4张彦芳,严怀秀.CD44与肿瘤关系的研究进展[J].中国冶金工业医学杂志,2005,22(1):21-22. 被引量:2
  • 5Marroquin C E, Downey L, Guo H, et al. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells[J]. Immunol Lett,2004,95(1) : 109-112. 被引量:1
  • 6Chellaiah M A, Biswas R S, Rittling S R, et al. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption inosteoclasts[J]. J Biol Chem, 2003, 278(31), 29086-29097. 被引量:1
  • 7Gao C, Guo H, Downey L, et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells[J]. Carcinogenesis,2003,24 (12) : 1871 - 1878. 被引量:1
  • 8Hema R, Anuradha B, Gopal C. Kundu Osteopontin: role in cell signaling and cancer progression TRENDS in Cell Biology, 2006,16(2) :80-87. 被引量:1
  • 9Alper O, Bowden E T. Novel insights into c-Src[J]. Curr Pharm Des, 2005, 11(9), 1119-1130. 被引量:1
  • 10Moro L. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130 Cas and leads to phosphorylation of specific EGF receptor tyrosines[J]. J Biol Chem, 2002,277(11) :9405-9414. 被引量:1

二级参考文献13

  • 1王瑞年,朱延波,薛建元,蔡建春.胃癌浸润转移与整合蛋白、IV型胶原酶及细胞外基质的关系[J].中华病理学杂志,1994,23(5):278-281. 被引量:37
  • 2Sneath RJ, Mangham DC. CD44 isform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis[J]. Histopathology,2000;37(2) : 166. 被引量:1
  • 3Lu D, Tawfik O, Pantazis C. Altered expression of CD44 and variant isoforms in human adenocareinoma of the endoeervix during progression[ J ]. Gynecol, 1999 ; 75 ( 1 ) : 84. 被引量:1
  • 4Saito H, Tsujitani S, Katano K, et al. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma[ J ]. Cancer, 1998 ; 83 (6) : 1094. 被引量:1
  • 5Tran TA, Kallakury BVS, Sheehan CE, et al. Expression of CD44 standard form and variant isoforms in non - small cell lung carcinomas[J]. Hum Pathol, 1997 ;28(7) :809. 被引量:1
  • 6Fasano M, Sabatini MT, Wieczored R, et al. CD44 and its V6 spliced variant in lung tumors: a role in histogenesis? [J]. Cancer, 1997 ; 80(1):34. 被引量:1
  • 7Yamaguchi A, Goi T, Seki K, et al. Clinical significance of combined immunohistochemical detection of CD44V and sialyl lex expression for colorectal cancer patients undergoing curative resectlon[J]. Oncology,1998;55(5) :400. 被引量:1
  • 8Kaufmann M, Heider KH, Sinn HP, et al. CD44 varlant exon epitopes in primary breast cancer and length of surrival[J]. The Lancet, 1995;345(8950) :615. 被引量:1
  • 9Niitsu N, Iijima K. High serum soluble CD44 is correlated with a poor outcome of aggressive non - Hodgkin's lyrnphoma [ J ]. Leukemia Research, 2002 ; 26 (3) : 241. 被引量:1
  • 10Ladeda V, Aguirre U, Ghiso JA, et al. Function and expression of CD44 during spreading migration and invasion of murine carcinoma cells [J]. Exp Cell Res, 1998 ;242(2) :515. 被引量:1

共引文献8

同被引文献125

引证文献11

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部